Chapter 17
Substance Misuse in First-Episode Psychosis
Ian Wilson,
Ian Wilson
Teaching Fellow
Manchester Dual Diagnosis Service, Manchester Mental Health and Social Care Trust and Teaching Fellow, University of Manchester, Manchester, UK
Search for more papers by this authorIan Wilson,
Ian Wilson
Teaching Fellow
Manchester Dual Diagnosis Service, Manchester Mental Health and Social Care Trust and Teaching Fellow, University of Manchester, Manchester, UK
Search for more papers by this authorBook Editor(s):Paul French,
Jo Smith,
David Shiers,
Mandy Reed,
Mark Rayne,
Paul French
Associate Director Honorary Senior Lecturer
Greater Manchester West Mental Health NHS Foundation Trust, Manchester, UK
School of Psychological Sciences, University of Manchester, UK
Search for more papers by this authorJo Smith
NMHDU Joint National Early Intervention Programme, Lead and Worcestershire EI Clinical Development Lead, Worcestershire Mental Health Partnership NHS Trust, Worcestershire, UK
Search for more papers by this authorDavid Shiers
NMHDU Joint National Early Intervention Programme Lead Worcestershire, UK
Search for more papers by this authorMandy Reed
Consultant Nurse
Early Intervention in Psychosis, Bath, UK
Search for more papers by this authorMark Rayne
Programme Specialist
Service Development NHS West Midlands Regional, Development Centre, West Midlands, UK
Search for more papers by this authorFirst published: 26 March 2010
Summary
This chapter contains sections titled:
-
Introduction
-
Prevalence rates in dual diagnosis
-
Effective interventions for dually diagnosed clients
-
Dual diagnosis and early intervention
-
What are the patterns of drug use in the UK?
-
Why do young people take drugs?
-
Cannabis and mental health
-
Detecting drug and alcohol use
-
What can we do?
-
Conclusion
-
Useful websites
-
Suggested further reading
-
References
Useful websites
- www.csip.org.uk/mentalhealthandcannabis Care Services Improvement Partnership, Cannabis Toolkit
- www.youngminds.org.uk/cannabis Young Minds
- www.eastmidlands.csip.org.uk/dd/index Education material – Out Of Your Heads guides (Mark Holland & Mike Linnell)
- www.drugs.gov.uk
- www.talktofrank.com
- www.knowcannabis.org.uk
- Suggested further reading
- Baker, A. & Velleman, R. (2006). Clinical Handbook of Co-existing Mental Health and Drug and Alcohol Problems. London: Routledge.
- Graham, H.L., Copello, A., Birchwood, M.J. & Mueser, K.T. (2003). Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery. Chichester: Wiley.
- Miller, W. & Rollnick, S. (2002). Motivational Interviewing: Preparing People to Change Addictive Behaviour. New York: Guilford Press.
- References
- Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A. & Moffitt, T.E. (2002). Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. British Medical Journal, 325, 1212–1213.
- Banerjee, S., Clancy, C. & Crome, I. (2002). Co-existing Problems of Mental Disorder and Substance Misuse (Dual Diagnosis): An Information Manual. London: Royal College of Psychiatrists Research Unit.
- Barnett, J., Werners, U., Secher, S. et al. (2007). Substance use in a population based clinic sample of people with first episode psychosis. British Journal of Psychosis, 190, 515–520.
- Barrowclough, C., Haddock, G., Tarrier, N. et al. (2001). Randomised controlled trial of MI, CBT and FI for patients with co-morbid schizophrenia and SUD. American Journal of Psychiatry, 158, 1706–1713.
- Barrowclough, C., Haddock, G., Lowens, I. et al. (2007). Psychosis and drug and alcohol problems. In: A. Baker & R. Velleman (eds), A Clinical Handbook of Co-existing Mental Health and Drug and Alcohol Problems. London: Routledge.
- Brunette, M.F., Drake, R.E., Woods, M. & Hartnett, T. (2001). A comparison of long-term and short-term residential treatment programmes for DD patients. Psychiatric Services, 52, 526–528.
- Cantwell, R., Brewin, J., Glazebrook, C. et al. (1999). Prevalence of substance use in first-episode psychosis. British Journal of Psychiatry, 174, 150–153.
- Carmichael, D., Tackett-Gibson, M., Dell, O. et al. (1998). Texas DD Project Evaluation Report, 1997– 1998. College Station, Texas: A&M University Public Policy Research Institute.
- Costa e Silva (2002). Evidence based analysis of the worldwide abuse of licit and illicit drugs. Human Psychopharmacology, 17, 131–140.
- Department of Health (2002). Mental Health Policy Implementation Guidelines for Dual Diagnosis. London: Department of Health.
- Department of Health (2003). Knowledge and Skills Framework. London: Department of Health.
- Department of Health (2004a). Mental Health Care Group Workforce Team: National Mental Health Workforce Strategy. London: Department of Health.
- Department of Health (2004b). Management Standards Consultancy for Skills for Health – Drugs and Alcohol Occupational Standards. London: Department of Health.
- Department of Health (2004c). The Ten Essential Shared Capabilities – A Framework for the Whole of the Mental Health Workforce. London: Department of Health.
- Detrick, A. & Stiepock, V. (1992). Treating persons with mental illness, substance abuse and legal problems: The Rhode Island experience. New Directions for Mental Health Services, 56, 65–77.
- Dodd, T., Nicholas, S., Povey, D. & Walker, A. (2004). Crime in England and Wales 2003/2004. London: Home Office Statistical Bulletin.
- Drake, R.E., McHugo, G.J., Clark, R.E. et al. (1998). Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder. A clinical trial. American Journal of Orthopsychiatry, 68, 201–215.
- Drake, R.E., McHugo, G.J., Xie, H., Fox, M., Packard, J. & Helmstetter, B. (2006). Ten year recovery outcomes for clients with co-occurring schizophrenia and SUD. Schizophrenia Bulletin, 32 (3), 464–473.
- Duke, P.J., Pantelis, C. & Barnes, T.R. (1994). South Westminster Schizophrenia Survey: Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. British Journal of Psychiatry, 164, 630–636.
- Edwards, J., Elkins, K., Hinton, M. et al. (2006). Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatrica Scandinavica, 114 (2), 109–117.
- European Monitoring Centre for Drug & Drug Addiction (2001). 2001 Annual Report on the State of the Drugs Problem in the European Union. Brussels: European Monitoring Centre for Drug & Drug Addiction.
- Gibbins, J. & Kipping, C. (2006). Coexistent substance use and psychiatric disorders. In: C. Gamble & G. Brennan (eds), Working With Serious Mental Illness. Edinburgh: Elsevier.
- Godley, S.H., Hoewing-Roberson, R. & Godley, M.D. (1994). Final MISA Report. Bloomington Illinois: Lighthouse Institute.
- Graham, H. (2003). A cognitive conceptualisation of concurrent psychosis and problem drug and alcohol use. In: H. Graham, A. Capello, M. Birchwood & K. Mueser (eds), Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery. Chichester: John Wiley.
- Green, B., Young, R. & Kavanagh, D. (2005). Cannabis use and misuse prevalence among people with psychosis. British Journal of Psychiatry, 187, 306–313.
- Haddock, G., Barrowclough, C., Tarrier, N. et al. (2003). Cognitive behavioural therapy and motivational intervention for schizophrenia and substance misuse – 18 month outcomes of a randomised controlled trial. British Journal of Psychiatry, 183, 418–426.
- Ho, A.P., Tsuang, J.W., Liberman, R.P. et al. (1999). Achieving effective treatment of patients with chronic psychotic illness and co morbid substance dependence. American Journal of Psychiatry, 156, 1765–1770.
- Holland, M. & Linell, M. (2007). The “Out of Your Head” Guides. Manchester, Lifeline Publications. www.lifelinepublications.org.uk/[email protected].
- Hughes, L. (2006). Closing the Gap, Essential Shared Capabilities for Working with Dual Diagnosis. University of Lincoln: Centre for Clinical & Workforce Innovation.
- Jerrell, J.M. & Ridgely, M.S. (1995). Comparative effectiveness of three approaches to serving people with severe mental illness and SUD. Journal of Nervous & Mental Disease, 183, 566–576.
- Ley, A., Jeffery, D.P., McClaren, S. & Seigfried, N. (1999). Treatment programmes for people with both severe mental illness and substance misuse. (Cochrane Review), Cochrane Library Issue 2 Oxford: Update Software.
- Menezes, P., Johnson, S., Thornicroft, G. et al. (1996). Drug and alcohol problems among people with severe mental illness in South London. British Journal of Psychiatry, 168, 612–619.
- Miller, W. & Rollnick, S. (2002). Motivational Interviewing: Preparing People to Change Addictive Behaviour. New York: Guilford Press.
- Moore, T.H., Zammit, S., Lingford-Hughes, A. et al. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. The Lancet, 370, 319–328.
- Regier, D., Farmer, N. & Rae, D. (1990). Co-morbidity of mental disorders with alcohol and other drugs of abuse: Results from the Epidemiological Catchment Area (ECA). JAMA: The Journal of the American Medical Association, 264 (19), 2511–2518.
- Schulte, S. & Holland, M. (2008). Dual Diagnosis in Manchester, UK: Practitioners' Estimates of Prevalence Rates in Mental Health and Substance Misuse Services. Mental Health and Substance Use: Dual Diagnosis 1, 2, 118–124.
- van Os, J., Bak, M., Hanssen, M., Bijl R., de Graaf, R. & Verdoux, H. (2002). Cannabis use & psychosis: A longitudinal population study. American Journal of Epidemiology, 156, 319–327.
- Weaver, T., Madden, P., Charles, V., Stimson, G. & Renton, A. (2003). Co-morbidity of substance misuse and mental illness in community mental health and substance misuse. British Journal of Psychiatry, 183, 304–313.
- Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I. & Lewis, G. (2002). Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study. British Medical Journal, 325, 1199–1203.
